2m 2m 2m 2m 2m 2m 2m
CLEARPOINT NEURO (CLPT)
NASDAQ
$18.41-$0.12 (-0.67%)
Price as of Jun 23, 2026 7:57 PM EDT- $511.6MMarket Cap
- 59.33%1-Year Change
- Medical DevicesIndustry
CLEARPOINT NEURO (CLPT)
$18.41-$0.12 (-0.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 23.9M -23.99% | 31.4M +31.04% | 24.0M +16.56% | 20.6M +26.09% | |
Cost of Revenue | 14.3M +16.39% | 12.3M +18.63% | 10.3M +47.31% | 7.0M +40.18% | |
Gross Profit | 22.7M +18.67% | 19.1M +40.46% | 13.6M +0.61% | 13.5M +19.84% | |
Sales and Marketing Expense | 16.5M +13.70% | 14.5M +14.95% | 12.6M +34.59% | 9.4M +35.25% | |
Research and Development Expense | -13.9M +12.14% | -12.4M +5.83% | -11.7M -207.48% | 10.9M +21.25% | |
Depreciation and Amortization Expense | 168,000 -82.86% | 980,000 +56.55% | 626,000 +156.56% | 244,000 +53.46% | |
Total Operating Expenses | 16.5M +37.51% | 12.0M +2.06% | 11.8M +22.32% | 9.6M +9.70% | |
Operating Profit | -24.2M +22.37% | -19.7M -12.03% | -22.4M +37.44% | -16.3M +22.12% | |
Interest Income | 1.2M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -81,000 -91.68% | |
Interest Income and Expense and Net | 1.2M N/A | 0 N/A | 0 -100.00% | 81,000 -91.68% | |
Total Nonoperating Income and Expense | -146,000 +265.00% | -40,000 +37.93% | -29,000 +31.82% | -22,000 -65.08% | |
Income before Taxes | -25.5M +29.06% | -19.7M -12.03% | -22.4M +37.44% | -16.3M +22.12% | |
Income Taxes | 55,000 +358.33% | 12,000 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -25.5M +35.03% | -18.9M -14.37% | -22.1M +34.40% | -16.4M +14.05% | |
Net Income from Continuing Operations Applicable to Common | -25.5M +34.74% | -18.9M -14.37% | -22.1M +34.40% | -16.4M +14.05% | |
Basic EPS and Net Income | -0.90 +28.57% | -0.70 -22.22% | -0.90 +32.35% | -0.68 -1.45% | |
Diluted EPS and Net Income | -0.90 +28.57% | -0.70 -22.22% | -0.90 +32.35% | -0.68 -1.45% | |
Basic Weighted Average Shares | 28.3M +4.76% | 27.0M +9.85% | 24.6M +1.75% | 24.2M +16.63% | |
Diluted Weighted Average Shares | 28.3M +4.76% | 27.0M +9.85% | 24.6M +1.75% | 24.2M +16.63% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 45.9M +128.43% | 20.1M -13.12% | 23.1M -16.20% | 27.6M -48.96% | |
Short-Term Investments | N/A N/A | N/A N/A | 0 -100.00% | 9.9M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 45.9M +128.43% | 20.1M -13.12% | 23.1M -38.28% | 37.5M -30.72% | |
Total Current Assets | 63.6M +90.63% | 33.4M -7.77% | 36.2M -29.32% | 51.2M -17.31% | |
Accumulated Depreciation | 1.7M +27.85% | 1.3M +42.12% | 945,000 -46.58% | 1.8M -6.35% | |
Property and Plant and Equipment and Net | 2.6M +30.72% | 2.0M +44.35% | 1.4M +72.33% | 806,000 +49.54% | |
Total Long-Term Assets | 1.7M +1,050.00% | 148,000 +35.78% | 109,000 -16.79% | 131,000 +4.80% | |
Total Assets | 97.7M +149.42% | 39.2M -8.14% | 42.7M -23.12% | 55.5M -15.39% | |
Income Taxes Payable | 354,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 10.8M +3.98% | 10.4M +39.34% | 7.4M +9.46% | 6.8M +42.82% | |
Total Long-Term Debt | 49.1M N/A | 0 -100.00% | 9.9M +0.57% | 9.9M +0.56% | |
Total Long-Term Liabilities | 489,000 -85.81% | 3.4M -16.11% | 4.1M +113.79% | 1.9M -12.76% | |
Total Liabilities | 69.7M +405.27% | 13.8M -35.78% | 21.5M +15.51% | 18.6M +10.77% | |
Retained Earnings | -216.9M +13.35% | -191.4M +10.97% | -172.5M +14.69% | -150.4M +12.27% | |
Total Stockholders Equity | 28.0M +10.36% | 25.4M +19.91% | 21.2M -42.60% | 36.9M -24.39% | |
Total Shares Outstanding | 29.4M +6.34% | 27.6M +12.03% | 24.7M +0.30% | 24.6M +3.86% | |
Cash Flow | |||||
Cash from Operating Activities | -23.9M +167.32% | -8.9M -34.77% | -13.7M -15.14% | -16.2M +27.33% | |
Capital Expenditures | 522,000 +89.82% | 275,000 -61.65% | 717,000 +183.40% | 253,000 +50.60% | |
Cash from Investing Activities | 615,000 +323.64% | -275,000 -103.07% | 8.9M +183.36% | -10.7M +6,290.48% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 50.2M +710.78% | 6.2M +1,990.88% | 296,000 -27.63% | 409,000 -99.13% | |
Financials Ratio | |||||
Gross Margin | 40.15% -34.09% | 60.92% +7.19% | 56.83% -13.68% | 65.84% -4.96% | |
Operating Margin | -101.28% +61.00% | -62.91% -32.87% | -93.70% +17.91% | -79.47% -3.15% | |
Return on Assets | -37.30% -19.29% | -46.22% +2.68% | -45.01% +65.79% | -27.15% -10.41% | |
Return on Equity | -95.64% +17.72% | -81.24% +6.77% | -76.09% +98.33% | -38.37% -31.89% | |
Revenue Growth | -23.99% -177.30% | 31.04% +87.38% | 16.56% -36.51% | 26.09% -3.55% | |
Current Ratio | 5.91 +83.34% | 3.22 -33.81% | 4.87 -35.43% | 7.54 -42.10% | |
Cash Ratio | 4.27 +119.68% | 1.94 -37.65% | 3.11 -23.45% | 4.07 -64.26% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow